Healthcare & Life Sciences

FinalDose

United Kingdom

pre-seed

Stage

Investors

About

FinalDose is developing a programmable therapeutic molecule capable of recognizing disease-associated DNA sequences to selectively kill matching cells, with an initial focus on cancer treatment.

Explore FinalDose's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.